Effect of chronic treatment with prazosin and L-arginine on the elevation of blood pressure during cold exposure.
Chronic exposure to cold (5 degrees C) is well known to increase both tyrosine hydroxylase (TH) activity in brown adipose tissue and systemic blood pressure. The effect of chronic dietary administration of the alpha-adrenergic antagonist, prazosin, and the amino acid, L-arginine, on both the elevation of blood pressure during exposure to cold and on TH activity and expression of TH mRNA in the adrenal glands of rats was studied. As observed previously, chronic exposure to cold increased systolic blood pressure significantly and induced cardiac hypertrophy. Chronic dietary treatment with prazosin (8 mg/kg food) and arginine (20 g/kg food) returned blood pressure to control levels, did not affect body weight significantly, but failed to prevent cardiac hypertrophy. Both prazosin and L-arginine reduced the drinking response to administration of angiotensin II. Treatment with arginine and prazosin was accompanied by a significant increase in the urinary outputs of dopamine and L-DOPA. The 3 cold-treated groups (control, L-arginine and prazosin) had increases in plasma T3 and decreases in plasma T4 and plasma renin activity. Plasma concentrations of epinephrine and norepinephrine were increased significantly in the L-arginine-treated group. TH mRNA and TH activity in the adrenal glands were increased in the 3 cold-treated groups and these measures were correlated directly and significantly with plasma norepinephrine and epinephrine concentrations. Although both prazosin and arginine prevented the cold-induced elevation of blood pressure, they did not prevent the increase in TH mRNA, TH activity or epinephrine in plasma. The protective effect of arginine and prazosin in cold-induced hypertension may be related both to their reduction in plasma renin activity and to a reduced responsiveness to angiotensin II, as well as to their abilities to increase the secretion of dopamine.
Fregly
M J
MJ
Department of Physiology, University of Florida, College of Medicine, Gainesville 32610-0274.
Rossi
F
F
Sun
Z
Z
Tümer
N
N
Cade
J R
JR
Hegland
D
D
Yürekli
M
M
D000311:Adrenal Glands / Q000378:metabolism; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001120:Arginine / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D006332:Cardiomegaly / Q000097:blood / Q000209:etiology / Q000652:urine; D003080:Cold Temperature; D004837:Epinephrine / Q000097:blood; D006973:Hypertension / Q000097:blood / Q000209:etiology / Q000517:prevention & control* / Q000652:urine; D007980:Levodopa / Q000652:urine; D008297:Male; D011224:Prazosin / Q000494:pharmacology*; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D013312:Stress, Physiological / Q000150:complications; D013963:Thyroid Hormones / Q000097:blood; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D012333:RNA, Messenger; D013963:Thyroid Hormones; D000804:Angiotensin II; D007980:Levodopa; D001120:Arginine; D014446:Tyrosine 3-Monooxygenase; D011224:Prazosin; D004837:Epinephrine